Cargando…
Survivin, a molecular target for therapeutic interventions in squamous cell carcinoma
Squamous cell carcinoma (SCC) is the most common cancer worldwide. The treatment of locally advanced disease generally requires various combinations of radiotherapy, surgery, and systemic therapy. Despite aggressive multimodal treatment, most of the patients relapse. Identification of molecules that...
Autores principales: | Khan, Zakir, Khan, Abdul Arif, Yadav, Hariom, Prasad, Godavarthi B. K. S., Bisen, Prakash Singh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5415770/ https://www.ncbi.nlm.nih.gov/pubmed/28536639 http://dx.doi.org/10.1186/s11658-017-0038-0 |
Ejemplares similares
-
Molecular Microbiological Testing
por: Debnath, Mousumi, et al.
Publicado: (2009) -
Diagnosis and Monitoring of Infections
por: Debnath, Mousumi, et al.
Publicado: (2009) -
Molecular docking analysis of aplysin analogs targeting survivin protein
por: Shakeel, Eram, et al.
Publicado: (2017) -
System biological investigations of hydroxychloroquine and azithromycin targets and their implications in QT interval prolongation
por: Khan, Abdul Arif, et al.
Publicado: (2020) -
Survivin expression in oral squamous cell carcinoma
por: Muzio, L Lo, et al.
Publicado: (2003)